2022. Clinical implications, safety, efficacy of Recombinant Human Granulocyte Colony-Stimulating Factors and Pegylated Equivalent. Epidemiology, Biostatistics, and Public Health. 10, 4 (Jul. 2022). DOI:https://doi.org/10.2427/8845.